JPMorgan Chase Adjusts Price Target on UnitedHealth to $652 From $559
Stifel Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $475
Barclays Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $475
Microsoft Earnings Are Coming. An Analyst Sees Big Upside for the Stock. -- Barrons.com
Centene Downgraded at Jefferies Amid Higher Medicaid Utilization
Deutsche Bank Adjusts Price Target on Goldman Sachs Group to $500 From $400, Maintains Hold Rating
China Renaissance Adjusts Price Target on Microsoft to $520 From $470, Maintains Buy Rating
Cantor Fitzgerald Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $591
UnitedHealth Group Analyst Ratings
Redburn Atlantic Adjusts Price Target on Goldman Sachs to $450 From $400
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Microsoft Analyst Ratings
Microsoft Remains a Strong Buy; Azure, AI Momentum Overshadows Outage Panic
BNP Paribas Exane Adjusts Price Target on Microsoft to $525 From $495, Maintains Outperform Rating
Buy Rating on UnitedHealth Group: Proactive Management and Strong Growth Outlook
BNP Paribas Exane Adjusts Price Target on Goldman Sachs to $485 From $415, Maintains Neutral Rating
Jefferies Adjusts Price Target on Amgen to $380 From $375
Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
UnitedHealth Group Analyst Ratings